Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

1994

Baliga P, Chavin KD, Qin L, Woodward J, Lin J, Linsley PS, et al. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation. 1994;58(10):1082-90.

Florio T, Rim C, Hershberger RE, Loda M, Stork PJ. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol. 1994;8(10):1289-97.

Inghirami G, Lederman S, Yellin MJ, Chadburn A, Chess L, Knowles DM. Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma. Blood. 1994;84(3):866-72.

Crowson AN, Magro CM. Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus. J Am Acad Dermatol. 1994;31(3 Pt 1):515-6.

McCaffrey TA, Falcone DJ, Borth W, Weksler BB. Alpha 2-macroglobulin/transforming growth factor-beta 1 interactions. Modulation by heparin-like molecules and effects on vascular smooth muscle cells. Ann N Y Acad Sci. 1994;737:368-82.

Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, et al. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem. 1994;269(50):31706-10.

Iberti TJ, Miller M, Abalos A, Fischer EP, Post KD, Benjamin E, et al. Abnormal coagulation profile in brain tumor patients during surgery. Neurosurgery. 1994;34(3):389-94; discussion 394-5.

Chavin KD, Qin L, Yon R, Lin J, Yagita H, Bromberg JS. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade. J Immunol. 1994;152(8):3729-39.

Hoda SA, Shafiq-Hoda R. "Chewing gum" and "corn flakes": similes in cytopathology. Diagn Cytopathol. 1994;10(4):397.

Hoda SA, Horenstein M, Gerber MA. Additional comments on the value of the autopsy for the 1990s. Hum Pathol. 1994;25(8):839-40.